Although these studies do not examine the impact of the estrogen/ER axis in cancer specifically, the above results may hint at similar regulation mechanisms existing in the context of BC and advocate for the need for future studies to clearly delineate the role and impact of ER signaling in immune cells in the setting of BC. The gene discussed is ESR1; the disease is breast cancer.